SlideShare a Scribd company logo
1 of 78
Complications of Peritoneal Dialysis Abhijit Kontamwar,MD Renal Consultants, Inc  Clinical Assistant Professor of Internal Medicine at NEOUCOM (Northeastern Ohio Universities Colleges of Medicine and Pharmacy).
Complications  ,[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object],[object Object]
Infectious complications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Causes of transfer to HD among PD patients Mujais et al; Kidney Int Suppl 2006; 70: S21-36
Hospitalization rates for access related infections Chavers et al, J Am Soc Nephrol 18: 952 – 959, 2007
Peritonitis  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
How does bacteria gain entry into peritoneal cavity? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pathophysiology  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Flush before fill ,[object Object],[object Object],[object Object],[object Object]
Diagnosis  ,[object Object],[object Object],[object Object],[object Object]
Specimen collection and processing  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Microbiology  Friedrich et al, Kidney Int, Oct 1992; 42: 967-974
Microbiology Mujais, S. Microbiology and outcomes of peritonitis in North America. Kidney Int 2006; 70:S55
Gram +ive organisms ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Gram –ve organisms ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Empiric Therapy Initiate empiric therapy Simultaneous gram +ve and gram –ve coverage For prevention of fibrin occlusion  heparin 500 U/L can be used Gram +ve coverage: 1 st  generation cephalosporin  or vancomycin Gram –ve coverage: 3 rd  generation cephalosporin  or aminoglycoside
Empiric therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Mode of antibiotic administration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Staph. aureus peritonitis Staph. Aureus on culture D/c gram –ve coverage, cont. gram +ve  coverage for 3 weeks If MRSA change to Vancomycin and rifampin can  be added (600 mg/day for 1 week) If clinical improvement continue  for 3 weeks If no clinical improvement  reculture and revaluate for exit-site or tunnel Infection or intra-abd abscess If peritonitis with exit-site or tunnel  Infection – remove catheter Allow 2 weeks rest period before reinitiating PD If no improvement in 5 days on appropriate  antibiotics, remove catheter
Enterococcus/Streptococcus peritonitis Enterococcus/Strep on culture D/c empiric coverage Start continuous Ampicillin 125 mg/L each bag Consider adding aminoglycoside for enterococcus If ampicillin resistant, start vanco; If VRE consider quinupristin/dalfopristin or linezolid Clinical improvement; treat for  2 weeks – strep 3 weeks - enterococcus No improvement, reculture  and evaluate for exit-site or tunnel infection Peritonitis with exit or tunnel infection Consider catheter removal Treat for 3 weeks In no improvement by 5 days, remove catheter
Pseudomonas peritonitis Pseudomonas on culture W/o exit-site/tunnel infection With exit-site/tunnel infection Remove catheter Use 2 abx with different mechanism Oral quinolone, cephalosporin, piperacillin based on sensitivities If clinical improvement Treat for 3 weeks If no improvement reculture and evaluate If no improvement by 5 days on  appropriate abx, remove catheter
Gram negative organism peritonitis Single gram –ve  organism on culture E. coli, klebsiella  or proteus Stenotrophomonas  3 rd  generation cephalosporin: ceftazidime or cefepime Two drugs with different mechanisms based on sensitivity pattern Duration of therapy: 3 weeks Duration of therapy: 3-4 weeks If no clinical improvement by 5 days, remove catheter
Polymicrobial peritonitis Polymicrobial peritonitis Multiple gram –ve organisms Multiple gram +ve organisms   Change to metronidazole In conjunction with ampicillin, Ceftazidime or aminoglycoside Surgical evaluation Laprotomy for suspected intra-abd pathology/abscess with catheter removal Continue therapy based on sensitivities W/o catheter infection, treat for 3 weeks With catheter infection, remove catheter
Culture negative peritonitis Culture negative peritonitis 24-48 hours Continue initial therapy If culture negative for 72 hours Repeat cell count and diff Infection resolving, pt improving Infection not resolving Cont initial therapy for 2 weeks, But D/c aminoglycoside if used initially Special culture techniques for Mycobacteria or legionella Culture positive Culture negative Adjust therapy as per sensitivity patterns If no improvement in 5 days, Consider catheter removal
Other causes of peritonitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Antibiotic dosing recommendations for CAPD LD: loading dose in mg, MD: maintenance dose in mg Antibiotic Intermittent Continuous Gentamicin  0.6 mg/kg LD 8, MD 4 Amikacin 2 mg/kg LD 25, MD 12 Cefazolin 15 mg/kg LD 500, MD 125 Cefepime 1 gm LD 500, MD 125 Cephalothin 15 mg/kg LD 500, MD 125 Ceftazidime 1 – 1.5 gm LD 500, MD 125 Ciprofloxacin  No data LD 50, MD 25 Vancomycin 15-30 mg/kg every 5-7 days LD 1000, MD 25 Aztreonam No data LD 1000, MD 250 Amphotericin NA 1.5 Imipenem/cilistatin 1 gm bid LD 500, MD 200
Intermittent dosing of antibiotics in APD ,[object Object],[object Object],[object Object],[object Object]
Catheter removal in peritonitis patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Other causes of cloudy effluent ,[object Object],[object Object],[object Object]
Eosinophilic peritonitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PD catheter removal after transplant ,[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Other causes of abdominal pain in PD patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Exit-site/Tunnel infection ,[object Object],[object Object],[object Object],[object Object]
 
Treatment of exit-site/tunnel infection Purulent discharge from exit-site Do culture/gram stain Gram +ve organism Gram –ve organism 1 st  generation Cephalosporin PO PO Quinolones If slow improvement or severe Cases add Rifampin 600mg/day If Pseudomonas and  no improvement  add 2 nd   anti-pseudomonal; ceftazidime IP Infection resolving; cont  treatment for 2 weeks Infection resolving; cont  treatment for 2 weeks Infection unresolved in 3-4 weeks; consider catheter revision/removal Infection unresolved in 3-4 weeks; consider catheter revision/removal
[object Object]
Non-infectious complications Non infectious  complications Catheter related Catheter unrelated ,[object Object],[object Object],[object Object],[object Object],[object Object],GERD Hemoperitoneum Back/abdominal pain UF failure Abdominal wall herniation Peritoneal sclerosis Pleural effusion Metabolic
Case  ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
Outflow failure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diagnosis  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object]
Pericatheter leakage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pericatheter leakage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pericatheter leakage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object],[object Object]
 
Pleural effusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pleural effusion ,[object Object],[object Object],[object Object],[object Object],[object Object]
Pleural effusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pleural effusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Catheter cuff extrusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Intestinal perforation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Bleeding exit-site ,[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object]
Hemoperitoneum  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],During training, warn females in advance!
Hemoperitoneum ,[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object]
GERD and delayed gastric emptying ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Back pain ,[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object]
Peritoneal Scintigram
 
Hernia  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dialysate infusion pain ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Metabolic  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Encapsulating peritoneal sclerosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EPS: Diagnosis  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
EPS: Treatment  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
Reynel Dan
 
Dialysis various modalities and indices used
Dialysis various modalities and indices usedDialysis various modalities and indices used
Dialysis various modalities and indices used
Abhay Mange
 
Anticoagulation in hemodialysis
Anticoagulation in hemodialysisAnticoagulation in hemodialysis
Anticoagulation in hemodialysis
Vishal Ramteke
 
Capd peritonitis mortalty
Capd peritonitis mortaltyCapd peritonitis mortalty
Capd peritonitis mortalty
xinnirah
 

What's hot (20)

Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
 
CRRT
CRRTCRRT
CRRT
 
ADEQUACY OF HEMODIALYSIS
ADEQUACY OF HEMODIALYSISADEQUACY OF HEMODIALYSIS
ADEQUACY OF HEMODIALYSIS
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
 
Continuous renal replacement therapy crrt
Continuous renal replacement therapy crrtContinuous renal replacement therapy crrt
Continuous renal replacement therapy crrt
 
Dialysis various modalities and indices used
Dialysis various modalities and indices usedDialysis various modalities and indices used
Dialysis various modalities and indices used
 
11 Peritoneal Dialysis
11 Peritoneal Dialysis11 Peritoneal Dialysis
11 Peritoneal Dialysis
 
Peritoneal dialysis catheter
Peritoneal dialysis catheterPeritoneal dialysis catheter
Peritoneal dialysis catheter
 
Vascular access
Vascular accessVascular access
Vascular access
 
Anticoagulation in hemodialysis
Anticoagulation in hemodialysisAnticoagulation in hemodialysis
Anticoagulation in hemodialysis
 
History of dialysis
History of dialysisHistory of dialysis
History of dialysis
 
Principles of-hemodialysis
Principles of-hemodialysisPrinciples of-hemodialysis
Principles of-hemodialysis
 
Peritoneal dialysis part1
Peritoneal dialysis part1Peritoneal dialysis part1
Peritoneal dialysis part1
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
DIALYSIS IN PREGNANCY.ppsx
DIALYSIS IN PREGNANCY.ppsxDIALYSIS IN PREGNANCY.ppsx
DIALYSIS IN PREGNANCY.ppsx
 
Dr alaa saleh complications of peritoneal dialysis (2)
Dr alaa saleh   complications of peritoneal dialysis (2)Dr alaa saleh   complications of peritoneal dialysis (2)
Dr alaa saleh complications of peritoneal dialysis (2)
 
Exit site infection in peritoneal dialysis patient
Exit site infection in peritoneal dialysis patientExit site infection in peritoneal dialysis patient
Exit site infection in peritoneal dialysis patient
 
Capd peritonitis mortalty
Capd peritonitis mortaltyCapd peritonitis mortalty
Capd peritonitis mortalty
 
Peritonitis, exit site care, catheter related infection
Peritonitis, exit site care, catheter related infectionPeritonitis, exit site care, catheter related infection
Peritonitis, exit site care, catheter related infection
 

Similar to Complications of peritoneal dialysis

MANAGEMENT OF INFECTIONS IN
MANAGEMENT OF INFECTIONS INMANAGEMENT OF INFECTIONS IN
MANAGEMENT OF INFECTIONS IN
NeurologyKota
 
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptxGI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
mekuriatadesse
 

Similar to Complications of peritoneal dialysis (20)

Febrile neutropaenia
Febrile neutropaeniaFebrile neutropaenia
Febrile neutropaenia
 
Complication peritoneal dailysis traning
Complication peritoneal dailysis traningComplication peritoneal dailysis traning
Complication peritoneal dailysis traning
 
Peritonitis
PeritonitisPeritonitis
Peritonitis
 
Febrile neutropenia ankur
Febrile neutropenia ankurFebrile neutropenia ankur
Febrile neutropenia ankur
 
clostridium Diarrhea
clostridium Diarrheaclostridium Diarrhea
clostridium Diarrhea
 
Uti policy-lec
Uti policy-lecUti policy-lec
Uti policy-lec
 
clostridium diarrhea
clostridium diarrheaclostridium diarrhea
clostridium diarrhea
 
Crohns Disease of the Anus
Crohns Disease of the AnusCrohns Disease of the Anus
Crohns Disease of the Anus
 
MANAGEMENT OF INFECTIONS IN
MANAGEMENT OF INFECTIONS INMANAGEMENT OF INFECTIONS IN
MANAGEMENT OF INFECTIONS IN
 
Case presentation Urosepsis
Case presentation UrosepsisCase presentation Urosepsis
Case presentation Urosepsis
 
seminar on urinary tract infection
seminar on urinary tract infectionseminar on urinary tract infection
seminar on urinary tract infection
 
Ascites related complications final
Ascites related complications finalAscites related complications final
Ascites related complications final
 
complication of peritoneal dialysis
complication of peritoneal dialysiscomplication of peritoneal dialysis
complication of peritoneal dialysis
 
Antibiotic associated diarrhea & Clostridium difficile infection
Antibiotic associated diarrhea & Clostridium difficile infectionAntibiotic associated diarrhea & Clostridium difficile infection
Antibiotic associated diarrhea & Clostridium difficile infection
 
Diagnosis and management of PID
Diagnosis and management of PIDDiagnosis and management of PID
Diagnosis and management of PID
 
Relapsing coagulase negative staphylococcus peritonitis
Relapsing coagulase negative staphylococcus peritonitis Relapsing coagulase negative staphylococcus peritonitis
Relapsing coagulase negative staphylococcus peritonitis
 
spontaneous bacterial peritonitis.pptx
spontaneous bacterial peritonitis.pptxspontaneous bacterial peritonitis.pptx
spontaneous bacterial peritonitis.pptx
 
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptxGI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
 
CAP PRESENTATION OKIKO (1).ppt
CAP PRESENTATION OKIKO (1).pptCAP PRESENTATION OKIKO (1).ppt
CAP PRESENTATION OKIKO (1).ppt
 
Differential Diagnosis of Cloudy effluent in Peritoneal Dialysis
Differential Diagnosis of Cloudy effluent in Peritoneal DialysisDifferential Diagnosis of Cloudy effluent in Peritoneal Dialysis
Differential Diagnosis of Cloudy effluent in Peritoneal Dialysis
 

More from Hofstra Northwell School of Medicine

More from Hofstra Northwell School of Medicine (20)

Amacing
AmacingAmacing
Amacing
 
Amacing
AmacingAmacing
Amacing
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
HSCT-TMA
HSCT-TMAHSCT-TMA
HSCT-TMA
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
HSCT-TMA
HSCT-TMAHSCT-TMA
HSCT-TMA
 
Acute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery PatientAcute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery Patient
 
Aki cticu final
Aki cticu finalAki cticu final
Aki cticu final
 
Primary hyperoxaluria and the Kidney
Primary hyperoxaluria and the KidneyPrimary hyperoxaluria and the Kidney
Primary hyperoxaluria and the Kidney
 
Obesity paradox
Obesity paradoxObesity paradox
Obesity paradox
 
Journal Club:Stem cells and Kidney Transplantation
Journal Club:Stem cells and Kidney TransplantationJournal Club:Stem cells and Kidney Transplantation
Journal Club:Stem cells and Kidney Transplantation
 
Proteinuria, A medical student prespective
Proteinuria, A medical student prespectiveProteinuria, A medical student prespective
Proteinuria, A medical student prespective
 
Journal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGSJournal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGS
 
FGF-23 and Mortality in Dialysis patients- Journal Club
FGF-23 and Mortality in Dialysis patients- Journal ClubFGF-23 and Mortality in Dialysis patients- Journal Club
FGF-23 and Mortality in Dialysis patients- Journal Club
 
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
 
Journal Club: Residual renal function
Journal Club: Residual renal functionJournal Club: Residual renal function
Journal Club: Residual renal function
 
Cystic disease of the kidney
Cystic disease of the kidneyCystic disease of the kidney
Cystic disease of the kidney
 
Viruses and the kidney
Viruses and the kidneyViruses and the kidney
Viruses and the kidney
 
Hematuria post transplant
Hematuria post transplantHematuria post transplant
Hematuria post transplant
 

Recently uploaded

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Recently uploaded (20)

How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 

Complications of peritoneal dialysis

  • 1. Complications of Peritoneal Dialysis Abhijit Kontamwar,MD Renal Consultants, Inc Clinical Assistant Professor of Internal Medicine at NEOUCOM (Northeastern Ohio Universities Colleges of Medicine and Pharmacy).
  • 2.
  • 3.
  • 4.
  • 5. Causes of transfer to HD among PD patients Mujais et al; Kidney Int Suppl 2006; 70: S21-36
  • 6. Hospitalization rates for access related infections Chavers et al, J Am Soc Nephrol 18: 952 – 959, 2007
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13. Microbiology Friedrich et al, Kidney Int, Oct 1992; 42: 967-974
  • 14. Microbiology Mujais, S. Microbiology and outcomes of peritonitis in North America. Kidney Int 2006; 70:S55
  • 15.
  • 16.
  • 17.
  • 18.
  • 19. Empiric Therapy Initiate empiric therapy Simultaneous gram +ve and gram –ve coverage For prevention of fibrin occlusion heparin 500 U/L can be used Gram +ve coverage: 1 st generation cephalosporin or vancomycin Gram –ve coverage: 3 rd generation cephalosporin or aminoglycoside
  • 20.
  • 21.
  • 22. Staph. aureus peritonitis Staph. Aureus on culture D/c gram –ve coverage, cont. gram +ve coverage for 3 weeks If MRSA change to Vancomycin and rifampin can be added (600 mg/day for 1 week) If clinical improvement continue for 3 weeks If no clinical improvement reculture and revaluate for exit-site or tunnel Infection or intra-abd abscess If peritonitis with exit-site or tunnel Infection – remove catheter Allow 2 weeks rest period before reinitiating PD If no improvement in 5 days on appropriate antibiotics, remove catheter
  • 23. Enterococcus/Streptococcus peritonitis Enterococcus/Strep on culture D/c empiric coverage Start continuous Ampicillin 125 mg/L each bag Consider adding aminoglycoside for enterococcus If ampicillin resistant, start vanco; If VRE consider quinupristin/dalfopristin or linezolid Clinical improvement; treat for 2 weeks – strep 3 weeks - enterococcus No improvement, reculture and evaluate for exit-site or tunnel infection Peritonitis with exit or tunnel infection Consider catheter removal Treat for 3 weeks In no improvement by 5 days, remove catheter
  • 24. Pseudomonas peritonitis Pseudomonas on culture W/o exit-site/tunnel infection With exit-site/tunnel infection Remove catheter Use 2 abx with different mechanism Oral quinolone, cephalosporin, piperacillin based on sensitivities If clinical improvement Treat for 3 weeks If no improvement reculture and evaluate If no improvement by 5 days on appropriate abx, remove catheter
  • 25. Gram negative organism peritonitis Single gram –ve organism on culture E. coli, klebsiella or proteus Stenotrophomonas 3 rd generation cephalosporin: ceftazidime or cefepime Two drugs with different mechanisms based on sensitivity pattern Duration of therapy: 3 weeks Duration of therapy: 3-4 weeks If no clinical improvement by 5 days, remove catheter
  • 26. Polymicrobial peritonitis Polymicrobial peritonitis Multiple gram –ve organisms Multiple gram +ve organisms Change to metronidazole In conjunction with ampicillin, Ceftazidime or aminoglycoside Surgical evaluation Laprotomy for suspected intra-abd pathology/abscess with catheter removal Continue therapy based on sensitivities W/o catheter infection, treat for 3 weeks With catheter infection, remove catheter
  • 27. Culture negative peritonitis Culture negative peritonitis 24-48 hours Continue initial therapy If culture negative for 72 hours Repeat cell count and diff Infection resolving, pt improving Infection not resolving Cont initial therapy for 2 weeks, But D/c aminoglycoside if used initially Special culture techniques for Mycobacteria or legionella Culture positive Culture negative Adjust therapy as per sensitivity patterns If no improvement in 5 days, Consider catheter removal
  • 28.
  • 29. Antibiotic dosing recommendations for CAPD LD: loading dose in mg, MD: maintenance dose in mg Antibiotic Intermittent Continuous Gentamicin 0.6 mg/kg LD 8, MD 4 Amikacin 2 mg/kg LD 25, MD 12 Cefazolin 15 mg/kg LD 500, MD 125 Cefepime 1 gm LD 500, MD 125 Cephalothin 15 mg/kg LD 500, MD 125 Ceftazidime 1 – 1.5 gm LD 500, MD 125 Ciprofloxacin No data LD 50, MD 25 Vancomycin 15-30 mg/kg every 5-7 days LD 1000, MD 25 Aztreonam No data LD 1000, MD 250 Amphotericin NA 1.5 Imipenem/cilistatin 1 gm bid LD 500, MD 200
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.  
  • 39. Treatment of exit-site/tunnel infection Purulent discharge from exit-site Do culture/gram stain Gram +ve organism Gram –ve organism 1 st generation Cephalosporin PO PO Quinolones If slow improvement or severe Cases add Rifampin 600mg/day If Pseudomonas and no improvement add 2 nd anti-pseudomonal; ceftazidime IP Infection resolving; cont treatment for 2 weeks Infection resolving; cont treatment for 2 weeks Infection unresolved in 3-4 weeks; consider catheter revision/removal Infection unresolved in 3-4 weeks; consider catheter revision/removal
  • 40.
  • 41.
  • 42.
  • 43.  
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.  
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 70.  
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.  
  • 77.  
  • 78.